Apricus Biosciences, Inc. (APRI) announced the closing of its agreement to own Finesco, by way of a share contribution.
Finesco is the French parent and holding company of Scomedica, a leading French healthcare contract sales and marketing organization.
Apricus said that Finesco and Scomedica will operate as wholly-owned subsidiaries of Apricus Bio.
The company stated that under the terms of the agreement, Finesco's existing shareholders contributed to Apricus Bio 100% of the outstanding common stock of Finesco in exchange for 2.6 million newly issued shares of Apricus Bio common stock valued at EURO7 million or US$8.8 million at the closing.
In addition, newly issued shares worth about EURO1.8 or US$2.3 million are due in the first quarter of 2013 if Scomedica achieves certain revenue milestones during 2012, Apricus Bio noted.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.